Clinical data from 113 patients with breast cancer.
| Factors | Neoadjuvant Chemotherapy Group | Control Group | χ2 | P |
|---|---|---|---|---|
| Number of Cases | 47 | 66 | ||
| Age(Years) | ||||
| Distribution | 28~61 | 30~65 | ||
| Average | 45 | 47 | ||
| State of Lymph node | 0.00 | >0.05 | ||
| MO* | 20 (42.55%) | 28 (42.42%) | ||
| Metastasis | 27 (57.46%) | 38 (57.58%) | ||
| Pathologic Type: IDC | ||||
| ER | 0.02 | >0.05 | ||
| ER(+) | 22 (46.81%) | 30 (45.45%) | ||
| ER(-) | 25 (53.19%) | 36 (54.55%) | ||
| Mode of Operation | ||||
| SRC* | 25 (53.19%) | 51 (77.27%) | 7.23 | <0.05 |
| BCT* | 22 (46.81%) | 15 (22.73%) |